INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, vol.25, no.7, pp.775-780, 2022 (SCI-Expanded)
Objective: Metabolic syndrome (MetS) is one of the preventable risk factors for cardiovascular disease (CVD). The aim of this study was to investigate the effect of MetS on CVD and cumulative organ damage in a multi-center, large cohort of patients with Takayasu arteritis (TAK).